Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Sep 10;93(11):500-509.
doi: 10.1212/WNL.0000000000008105. Epub 2019 Aug 14.

Practice guideline update summary: Pharmacologic treatment for pediatric migraine prevention: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society

Maryam Oskoui  1 , Tamara Pringsheim  1 , Lori Billinghurst  1 , Sonja Potrebic  1 , Elaine M Gersz  1 , David Gloss  1 , Yolanda Holler-Managan  1 , Emily Leininger  1 , Nicole Licking  1 , Kenneth Mack  1 , Scott W Powers  1 , Michael Sowell  1 , M Cristina Victorio  1 , Marcy Yonker  1 , Heather Zanitsch  1 , Andrew D Hershey  1
Affiliations
Review

Practice guideline update summary: Pharmacologic treatment for pediatric migraine prevention: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society

Maryam Oskoui et al. Neurology. .

Erratum in

Abstract

Objective: To provide updated evidence-based recommendations for migraine prevention using pharmacologic treatment with or without cognitive behavioral therapy in the pediatric population.

Methods: The authors systematically reviewed literature from January 2003 to August 2017 and developed practice recommendations using the American Academy of Neurology 2011 process, as amended.

Results: Fifteen Class I-III studies on migraine prevention in children and adolescents met inclusion criteria. There is insufficient evidence to determine if children and adolescents receiving divalproex, onabotulinumtoxinA, amitriptyline, nimodipine, or flunarizine are more or less likely than those receiving placebo to have a reduction in headache frequency. Children with migraine receiving propranolol are possibly more likely than those receiving placebo to have an at least 50% reduction in headache frequency. Children and adolescents receiving topiramate and cinnarizine are probably more likely than those receiving placebo to have a decrease in headache frequency. Children with migraine receiving amitriptyline plus cognitive behavioral therapy are more likely than those receiving amitriptyline plus headache education to have a reduction in headache frequency.

Recommendations: The majority of randomized controlled trials studying the efficacy of preventive medications for pediatric migraine fail to demonstrate superiority to placebo. Recommendations for the prevention of migraine in children include counseling on lifestyle and behavioral factors that influence headache frequency and assessment and management of comorbid disorders associated with headache persistence. Clinicians should engage in shared decision-making with patients and caregivers regarding the use of preventive treatments for migraine, including discussion of the limitations in the evidence to support pharmacologic treatments.

PubMed Disclaimer

Figures

Figure
Figure. Prevention studies from the 2004 guideline
See this image and copyright information in PMC

Comment in

References

    1. Victor TW, Hu X, Campbell JC, Buse DC, Lipton RB. Migraine prevalence by age and sex in the United States: a life-span study. Cephalalgia 2010;30:1065–1072. - PubMed
    1. Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 2018;38:1–211. - PubMed
    1. Lopez J, Bechtel KA, Rothrock JF. Pediatric headache [online]. Available at: emedicine.medscape.com/article/2110861-overview. Accessed February 28, 2015.
    1. Hershey AD, Powers SW, Vockell AL, LeCates S, Kabbouche MA, Maynard MK. PedMIDAS: development of a questionnaire to assess disability of migraines in children. Neurology 2001;57:2034–2039. - PubMed
    1. American Academy of Neurology. Clinical Practice Guideline Process Manual, 2011 ed. St. Paul: American Academy of Neurology; 2011.

Publication types

MeSH terms